How to develop the next generation of innovative therapeutic biologics to stand out from the competition? How to speed up from R&D to regulatory submission with differentiated product pipelines (antibodies, therapeutic vaccines, cell and gene therapy products, virus products)?How to make compliance with regulatory requirements when making bioprocess improvement changes? How to accelerate the clinical development of innovative biopharma and biosimilars? What factors should be considered in the mass production and plant construction of biopharma?......

One-stop-shop platform for reaching out to the entire Biopharmaceutical supply chain. 

A great opportunity to connect with China's market leaders, meet existing and potential clients, attend concurrent activities and forums, keep in step with top industry trends & regulations, find and purchase new launched products…